Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

: AstraZeneca shares slump after Phase 3 lung cancer drug study

Market Watch - 3 Jul 2023 14:35
AstraZeneca shares fell Monday after a late-stage study on a lung cancer drug disappointed investors.
Full Article at Market Watch

More Business News
2
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard